Literature DB >> 7979902

A metastasizing composite carcinoma of the thyroid with distinct medullary and papillary components.

R L Apel1, L C Alpert, A Rizzo, V A LiVolsi, S L Asa.   

Abstract

Thyroid tumors with differentiation of both parafollicular and follicular epithelial cells are rare. The majority of those reported have been composed of a single cell population with combined features of the two cell types. We describe a 48-year-old man with a thyroid tumor composed of two discrete cell populations: thyroglobulin-positive papillary carcinoma intermixed with calcitonin-containing medullary carcinoma. The tumor metastasized to regional lymph nodes and maintained this composite differentiation. We propose that such tumors with two discrete intermingled cell populations be called composite thyroid carcinomas, as opposed to mixed thyroid tumors, which describes tumors with a single cell population that exhibits features of two cell types. Dual differentiation in thyroid neoplasms has been interpreted as indicative of a common stem cell origin. In this case, the presence of two mature, highly differentiated elements may suggest a proliferative response of two distinct cell populations to a common tumorigenic stimulus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979902

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

1.  Combined "Mixed Medullary-Follicular" and "Papillary" Carcinoma of the Thyroid with Lymph Node Metastasis.

Authors:  Michio Shimizu; Mitsuyoshi Hirokawa; Virginia A. LiVolsi; Yuji Mizukami; Tanekazu Harada; Tomoo Itoh; Toshiaki Manabe
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

2.  Merged histological types of malignant thyroid tumor: experience and controversy.

Authors:  Liang Huang; Yan Zhang
Journal:  Med Oncol       Date:  2011-01-04       Impact factor: 3.064

3.  Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components.

Authors:  M Volante; M Papotti; J Roth; P Saremaslani; E J Speel; R V Lloyd; J A Carney; P U Heitz; G Bussolati; P Komminoth
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Spindle cell metaplasia arising in thyroid adenoma: characterization of its pathology and differential diagnosis.

Authors:  Y Shikama; H Mizukami; T Sakai; N Yagihashi; K Okamoto; S Yagihashi
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

5.  The Pathology of Medullary Carcinoma of the Thyroid: Review of the Literature and Personal Experience on 62 Cases.

Authors:  Mauro Papotti; Daniela Sambataro; Carla Pecchioni; Gianni Bussolati
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

6.  Composite metastatic carcinoma in lymph nodes of patients with concurrent medullary and papillary thyroid carcinoma: a report of two cases.

Authors:  Tomohisa Seki; Kaori Kameyama; Hiroshi Hayashi; Mitsuji Nagahama; Katsuhiko Masudo; Nobuhiro Fukunari; Kumi Tanaka; Kiminori Sugino; Koichi Ito; Hiroshi Takami
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

7.  Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation.

Authors:  G Papi; S Corrado; M G Pomponi; C Carapezzi; A Cesinaro; V A LiVolsi
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 8.  Immunohistochemical Biomarkers in Thyroid Pathology.

Authors:  Zubair Baloch; Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

9.  Simultaneous medullary and papillary thyroid cancer: two case reports.

Authors:  Gianlorenzo Dionigi; Patrizia Castano; Valentina Bertolini; Luigi Boni; Francesca Rovera; Maria Laura Tanda; Carlo Capella; Luigi Bartalena; Renzo Dionigi
Journal:  J Med Case Rep       Date:  2007-11-12

10.  Simultaneous medullary-papillary thyroid carcinoma.

Authors:  Faisal M H Al-Mashat
Journal:  Ann Saudi Med       Date:  2004 May-Jun       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.